Provided by Tiger Fintech (Singapore) Pte. Ltd.

vTv Therapeutics

17.61
-0.6550-3.59%
Post-market: 18.480.8750+4.97%17:46 EDT
Volume:66.18K
Turnover:1.17M
Market Cap:45.99M
PE:-2.51
High:19.20
Open:17.53
Low:17.11
Close:18.26
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

vTv Therapeutics Q4 2024 GAAP EPS $(0.55) Beats $(0.87) Estimate

Benzinga
·
13 mins ago

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

THOMSON REUTERS
·
15 mins ago

vTv Therapeutics Q4 Pretax Profit USD -4.437 Million

THOMSON REUTERS
·
15 mins ago

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

GlobeNewswire
·
16 mins ago

Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More

Zacks
·
5 hours ago

Alliance Global says clinical hold lift ‘de-risking’ event for vTv Therapeutics

TIPRANKS
·
17 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Blackstone, PepsiCo, Blue Owl Capital

Reuters
·
17 Mar

vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial

GuruFocus.com
·
17 Mar

VTv Therapeutics Shares Rise After FDA Lifts Hold on Diabetes Treatment

Dow Jones
·
17 Mar

BUZZ-vTv jumps after FDA lifts clinical hold on diabetes therapy

Reuters
·
17 Mar

vTv Therapeutics Shares up 22.6% as FDA Lifts Clinical Hold on Development of Co's Diabetes Therapy

THOMSON REUTERS
·
17 Mar

Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell

MT Newswires Live
·
17 Mar

vTv Therapeutics says FDA has lifted clinical hold on cadisegliatin program

TIPRANKS
·
17 Mar

vTv Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview

Reuters
·
07 Mar

vTv Therapeutics Inc - Steven Tuch to Resign as CFO Effective March 21

THOMSON REUTERS
·
27 Feb

vTv Therapeutics CFO Steven Tuch to Resign

TIPRANKS
·
27 Feb

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."